Emtricitabine

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Otherpeer-review

Abstract

Emtricitabine (also known as fluorocytidine or FTC) is the negative enantiomer of a thio analog of dideoxycytidine with a fluorine in the 5 position. Emtricitabine is a potent, synthetic nucleoside reverse transcriptase inhibitor with selective activity against HIV-1 and HIV-2 and hepatitis B virus (HBV).

Original languageEnglish
Title of host publicationKucers the Use of Antibiotics
Subtitle of host publicationA Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh Edition
PublisherCRC Press
Chapter231
Pages3801-3822
Number of pages22
ISBN (Electronic)9781498747967
ISBN (Print)9781498747950
Publication statusPublished - 1 Jan 2017

Cite this

Trevillyan, J., & Wright, E. (2017). Emtricitabine. In Kucers the Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh Edition (pp. 3801-3822). CRC Press.
Trevillyan, Janine ; Wright, Edwina. / Emtricitabine. Kucers the Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh Edition. CRC Press, 2017. pp. 3801-3822
@inbook{32c57bd33e3844c99169b15ed1bfc367,
title = "Emtricitabine",
abstract = "Emtricitabine (also known as fluorocytidine or FTC) is the negative enantiomer of a thio analog of dideoxycytidine with a fluorine in the 5 position. Emtricitabine is a potent, synthetic nucleoside reverse transcriptase inhibitor with selective activity against HIV-1 and HIV-2 and hepatitis B virus (HBV).",
author = "Janine Trevillyan and Edwina Wright",
year = "2017",
month = "1",
day = "1",
language = "English",
isbn = "9781498747950",
pages = "3801--3822",
booktitle = "Kucers the Use of Antibiotics",
publisher = "CRC Press",
address = "Australia",

}

Trevillyan, J & Wright, E 2017, Emtricitabine. in Kucers the Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh Edition. CRC Press, pp. 3801-3822.

Emtricitabine. / Trevillyan, Janine; Wright, Edwina.

Kucers the Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh Edition. CRC Press, 2017. p. 3801-3822.

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Otherpeer-review

TY - CHAP

T1 - Emtricitabine

AU - Trevillyan, Janine

AU - Wright, Edwina

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Emtricitabine (also known as fluorocytidine or FTC) is the negative enantiomer of a thio analog of dideoxycytidine with a fluorine in the 5 position. Emtricitabine is a potent, synthetic nucleoside reverse transcriptase inhibitor with selective activity against HIV-1 and HIV-2 and hepatitis B virus (HBV).

AB - Emtricitabine (also known as fluorocytidine or FTC) is the negative enantiomer of a thio analog of dideoxycytidine with a fluorine in the 5 position. Emtricitabine is a potent, synthetic nucleoside reverse transcriptase inhibitor with selective activity against HIV-1 and HIV-2 and hepatitis B virus (HBV).

UR - http://www.scopus.com/inward/record.url?scp=85056684681&partnerID=8YFLogxK

M3 - Chapter (Book)

SN - 9781498747950

SP - 3801

EP - 3822

BT - Kucers the Use of Antibiotics

PB - CRC Press

ER -

Trevillyan J, Wright E. Emtricitabine. In Kucers the Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh Edition. CRC Press. 2017. p. 3801-3822